These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23040114)

  • 1. Associations between hemoglobin level, resource use, and medical costs in patients with heart failure: findings from HF-ACTION.
    Reed SD; Li Y; Ellis SJ; Isitt JJ; Cheng S; Schulman KA; Whellan DJ
    J Card Fail; 2012 Oct; 18(10):784-91. PubMed ID: 23040114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-hospital resource use and medical costs in the last year of life by mode of death (from the HF-ACTION randomized controlled trial).
    Reed SD; Li Y; Dunlap ME; Kraus WE; Samsa GP; Schulman KA; Zile MR; Whellan DJ
    Am J Cardiol; 2012 Oct; 110(8):1150-5. PubMed ID: 22762718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
    Go AS; Yang J; Ackerson LM; Lepper K; Robbins S; Massie BM; Shlipak MG
    Circulation; 2006 Jun; 113(23):2713-23. PubMed ID: 16754803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic evaluation of the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) randomized controlled trial: an exercise training study of patients with chronic heart failure.
    Reed SD; Whellan DJ; Li Y; Friedman JY; Ellis SJ; Piña IL; Settles SJ; Davidson-Ray L; Johnson JL; Cooper LS; O'Connor CM; Schulman KA;
    Circ Cardiovasc Qual Outcomes; 2010 Jul; 3(4):374-81. PubMed ID: 20551371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between seattle heart failure model scores and medical resource use and costs: findings from HF-ACTION.
    Li Y; Levy WC; Neilson MP; Ellis SJ; Whellan DJ; Schulman KA; O'Connor CM; Reed SD
    J Card Fail; 2014 Aug; 20(8):541-7. PubMed ID: 24887579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health Care Costs for Patients with Heart Failure Escalate Nearly 3-Fold in Final Months of Life.
    Obi EN; Swindle JP; Turner SJ; Russo PA; Altan A
    J Manag Care Spec Pharm; 2016 Dec; 22(12):1446-1456. PubMed ID: 27882835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare resource use among heart failure patients in a randomized pilot study of a cognitive training intervention.
    Pressler SJ; Martineau A; Grossi J; Giordani B; Koelling TM; Ronis DL; Riley PL; Chou CC; Sullivan BJ; Smith DG
    Heart Lung; 2013; 42(5):332-8. PubMed ID: 23809197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemoglobin levels and new-onset heart failure in the community.
    Klip IT; Postmus D; Voors AA; Brouwers FP; Gansevoort RT; Bakker SJ; Hillege HL; de Boer RA; van der Harst P; van Gilst WH; van Veldhuisen DJ; van der Meer P
    Am Heart J; 2015 Jan; 169(1):94-101.e2. PubMed ID: 25497253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia.
    Ghali JK; Anand IS; Abraham WT; Fonarow GC; Greenberg B; Krum H; Massie BM; Wasserman SM; Trotman ML; Sun Y; Knusel B; Armstrong P;
    Circulation; 2008 Jan; 117(4):526-35. PubMed ID: 18195176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic significance of hemoglobin levels in patients with heart failure].
    Lupón J; Urrutia A; González B; Herreros J; Altimir S; Coll R; Prats M; Rey-Joly C; Valle V
    Rev Esp Cardiol; 2005 Jan; 58(1):48-53. PubMed ID: 15680131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resource use in the last 6 months of life among medicare beneficiaries with heart failure, 2000-2007.
    Unroe KT; Greiner MA; Hernandez AF; Whellan DJ; Kaul P; Schulman KA; Peterson ED; Curtis LH
    Arch Intern Med; 2011 Feb; 171(3):196-203. PubMed ID: 20937916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healthcare Costs for Acute Hospitalized and Chronic Heart Failure in South Korea: A Multi-Center Retrospective Cohort Study.
    Ku H; Chung WJ; Lee HY; Yoo BS; Choi JO; Han SW; Jang J; Lee EK; Kang SM
    Yonsei Med J; 2017 Sep; 58(5):944-953. PubMed ID: 28792137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry).
    Young JB; Abraham WT; Albert NM; Gattis Stough W; Gheorghiade M; Greenberg BH; O'Connor CM; She L; Sun JL; Yancy CW; Fonarow GC;
    Am J Cardiol; 2008 Jan; 101(2):223-30. PubMed ID: 18178411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of cost and health resource utilization for elderly patients with heart failure and diabetes mellitus.
    Bogner HR; Miller SD; de Vries HF; Chhatre S; Jayadevappa R
    J Card Fail; 2010 Jun; 16(6):454-60. PubMed ID: 20610226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of B-type natriuretic peptide and anemia in patients with and without heart failure: a substudy from the Breathing Not Properly (BNP) Multinational Study.
    Wu AH; Omland T; Wold Knudsen C; McCord J; Nowak RM; Hollander JE; Duc P; Storrow AB; Abraham WT; Clopton P; Maisel AS; McCullough PA;
    Am J Hematol; 2005 Nov; 80(3):174-80. PubMed ID: 16247751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. U.S. Carvedilol Heart Failure Study Group.
    Fowler MB; Vera-Llonch M; Oster G; Bristow MR; Cohn JN; Colucci WS; Gilbert EM; Lukas MA; Lacey MJ; Richner R; Young ST; Packer M
    J Am Coll Cardiol; 2001 May; 37(6):1692-9. PubMed ID: 11345386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anemia at Hospital Admission and Its Relation to Outcomes in Patients With Heart Failure (from the Polish Cohort of 2 European Society of Cardiology Heart Failure Registries).
    Tymińska A; Kapłon-Cieślicka A; Ozierański K; Peller M; Balsam P; Marchel M; Crespo-Leiro MG; Maggioni AP; Jankowska EA; Drożdż J; Filipiak KJ; Opolski G
    Am J Cardiol; 2017 Jun; 119(12):2021-2029. PubMed ID: 28434647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs and Resource Utilization Associated With Anemia and Rash in Chronic Hepatitis C Patients Treated With Direct-Acting Antiviral Agents in the United States.
    Le TK; Macaulay D; Kalsekar A; Yuan Y; Sorg RA; Wei J; Wu EQ
    Clin Ther; 2015 Aug; 37(8):1713-25.e3. PubMed ID: 26111918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anemia in chronic obstructive pulmonary disease: epidemiology and economic implications.
    Shorr AF; Doyle J; Stern L; Dolgitser M; Zilberberg MD
    Curr Med Res Opin; 2008 Apr; 24(4):1123-30. PubMed ID: 18331668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anemia and outcomes in patients with heart failure: a study from the National Heart Care Project.
    Kosiborod M; Curtis JP; Wang Y; Smith GL; Masoudi FA; Foody JM; Havranek EP; Krumholz HM
    Arch Intern Med; 2005 Oct; 165(19):2237-44. PubMed ID: 16246989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.